Congress has yet to approve bills to fund domestic and global health programs beyond the start of the new fiscal year, October 1. Policy differences between leaders in both the House and Senate have largely hobbled the annual appropriations process. |
The current standoff comes just as promising spending levels were proposed for some ID and HIV programs. After much advocacy by IDSA, HIVMA and other health groups, important funding increases were proposed for the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), Health Resources and Services Administration (HRSA), and the United States Agency for International Development (USAID).
For ID, a Senate subcommittee identified $30 million in new funding for the CDC to increase its efforts to address antimicrobial resistance, provided an increase to $32 million for the National Healthcare Safety Network (NHSN), continued support at $30 million for Advance Molecular Detection (AMD), sustained funding at $611 million for the Section 317 immunization program, continued support for the Biomedical Advanced Research and Development Authority (BARDA), and provided a marginal increase to the National Institute of Allergy and Infectious Diseases (NIAID) to $4.452 million.
In HIV, flat funding was provided for most HIV/AIDS-related programs with the exception of small increases for the AIDS Drug Assistance Program ($5 million). HIVMA was able to help secure favorable report language supporting the role of the NIH’s Office of AIDS Research and the subcommittee report also includes helpful language exempting scientific meetings from restrictions that have been placed on federal participation in conferences. In addition, the bill contains report language that would lift the ban on the use of federal funding to support syringe access programs. These developments would be erased if Congress fails to proactively move the FY2015 funding bills and reverts to the status quo, which would also entail additional across the board cuts.
IDSA and HIVMA will continue to advocate for robust federal funding for domestic and global ID and HIV/AIDS programs in FY 2015 and beyond. With just weeks until the start of the new fiscal year, it is now critically important that Congress be urged to complete the FY 2015 appropriations process. IDSA and HIVMA members are encouraged to take three minutes to email their members of Congress through the online Action Center.
< Previous Article | Next Article >